111 related articles for article (PubMed ID: 26477787)
21. High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.
Narimatsu S; Kobayashi N; Asaoka K; Masubuchi Y; Horie T; Hosokawa M; Ishikawa T; Ohmori S; Kitada M; Miyano J; Kataoka H; Yamamoto S
Chirality; 2001; 13(3):140-7. PubMed ID: 11270323
[TBL] [Abstract][Full Text] [Related]
22. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
[TBL] [Abstract][Full Text] [Related]
23. Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.
Eriksson UG; Lundahl J; Bäärnhielm C; Regårdh CG
Drug Metab Dispos; 1991; 19(5):889-94. PubMed ID: 1686232
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective metabolism of benalaxyl in liver microsomes from rat and rabbit.
Zhang P; Zhu W; Dang Z; Shen Z; Xu X; Huang L; Zhou Z
Chirality; 2011 Feb; 23(2):93-8. PubMed ID: 20544700
[TBL] [Abstract][Full Text] [Related]
27. Species differential stereoselective oxidation of a methylsulfide metabolite of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor dual agonist.
Karanam BV; Welch CJ; Reddy VG; Chilenski J; Biba M; Vincent S
Drug Metab Dispos; 2004 Oct; 32(10):1061-8. PubMed ID: 15229170
[TBL] [Abstract][Full Text] [Related]
28. Assessment of in vitro metabolic stability, plasma protein binding, and pharmacokinetics of E- and Z-guggulsterone in rat.
Chhonker YS; Chandasana H; Mukkavilli R; Prasad YD; Laxman TS; Vangala S; Bhatta RS
Drug Test Anal; 2016 Sep; 8(9):966-75. PubMed ID: 26608935
[TBL] [Abstract][Full Text] [Related]
29. Drug metabolism and pharmacokinetics of 4-substituted methoxybenzoyl-aryl-thiazoles.
Li CM; Lu Y; Narayanan R; Miller DD; Dalton JT
Drug Metab Dispos; 2010 Nov; 38(11):2032-9. PubMed ID: 20675405
[TBL] [Abstract][Full Text] [Related]
30. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice.
Ahn S; Kearbey JD; Li CM; Duke CB; Miller DD; Dalton JT
Drug Metab Dispos; 2011 Apr; 39(4):636-43. PubMed ID: 21233217
[TBL] [Abstract][Full Text] [Related]
31. [In vivo comparison of estradiol metabolism in liver microsomes of human, Beagle dog and rat].
Song YQ; Liao J; Liu HW; Ai CH; Zhang F
Yao Xue Xue Bao; 2012 Feb; 47(2):210-5. PubMed ID: 22512033
[TBL] [Abstract][Full Text] [Related]
32. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of carbosulfan. I. Species differences in the in vitro biotransformation by mammalian hepatic microsomes including human.
Abass K; Reponen P; Mattila S; Pelkonen O
Chem Biol Interact; 2009 Oct; 181(2):210-9. PubMed ID: 19523935
[TBL] [Abstract][Full Text] [Related]
34. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.
Prueksaritanont T; Balani SK; Dwyer LM; Ellis JD; Kauffman LR; Varga SL; Pitzenberger SM; Theoharides AD
Drug Metab Dispos; 1995 Jul; 23(7):688-95. PubMed ID: 7587955
[TBL] [Abstract][Full Text] [Related]
35. Determination of the in vitro metabolism of (+)- and (-)-epibatidine.
Watt AP; Hitzel L; Morrison D; Locker KL
J Chromatogr A; 2000 Oct; 896(1-2):229-38. PubMed ID: 11093658
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of troglitazone, an antidiabetic agent: prediction of in vivo stereoselective sulfation and glucuronidation from in vitro data.
Izumi T; Hosiyama K; Enomoto S; Sasahara K; Sugiyama Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1392-400. PubMed ID: 9067328
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
[TBL] [Abstract][Full Text] [Related]
38. Biotransformation of the anti-angiogenic compound SU5416.
Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
[TBL] [Abstract][Full Text] [Related]
39. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification.
Kumar GN; Jayanti V; Lee RD; Whittern DN; Uchic J; Thomas S; Johnson P; Grabowski B; Sham H; Betebenner D; Kempf DJ; Denissen JF
Drug Metab Dispos; 1999 Jan; 27(1):86-91. PubMed ID: 9884314
[TBL] [Abstract][Full Text] [Related]
40. Determination of metabolic profile of anti-malarial trioxane CDRI 99/411 in rat liver microsomes using HPLC.
Mishra S; Manickavasagam L; Jain GK
Biomed Chromatogr; 2012 Jan; 26(1):115-22. PubMed ID: 21503937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]